INDV (Indivior PLC) Stock Market Reviews

crown

search

Read and share opinions on INDV (Indivior PLC) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

INDV

Indivior PLC

clarify Drug Manufacturers - Specialty & Generic

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

4 Must-Buy Efficient Stocks to Enrich Your Portfolio in 2025
Nov 7, 2025
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
Nov 3, 2025
Indivior (INDV) Jumps to New High on Earnings Blowout, Optimistic Outlook
Oct 31, 2025
Indivior (INDV) Turns Profitable Despite $165 Million One-Off Loss, Challenging Bearish Narratives
Oct 31, 2025
Indivior PLC (INDV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Oct 30, 2025
Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates
Oct 30, 2025
Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance
Oct 30, 2025
Indivior to Participate in the Stifel 2025 Healthcare Conference
Oct 28, 2025
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th
Oct 16, 2025
Indivior (NasdaqGS:INDV): Fresh Clinical Data Prompts a Closer Look at Current Valuation
Oct 16, 2025
Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment
Oct 15, 2025
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation
Oct 1, 2025
Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M
Sep 30, 2025
What Makes Indivior PLC (INDV) a Strong Momentum Stock: Buy Now?
Sep 10, 2025

Reviews